News from the FDA/CDC

More deliveries now include opioid use disorder


 

FROM MMWR

The prevalence of opioid use disorder more than quadrupled among pregnant women at labor and delivery from 1999 to 2014, according to the Centers for Disease Control and Prevention.

Opioid use disorder in pregnant women at delivery, 1999-2014

The national prevalence of opioid use disorder increased by 333% as it went from 1.5 cases per 1,000 delivery hospitalizations in 1999 to 6.5 cases per 1,000 in 2014. At the state level, there were significant increases in all 28 states with data available for at least 3 consecutive years during the study period, Sarah C. Haight, MPH, and her associates at the CDC in Atlanta said in the Morbidity and Mortality Weekly Report.

Average annual rate changes for those states ranged from a low of 0.01 per 1,000 delivery hospitalizations per year in California to 5.37 per year in Vermont, with the national rate change coming in at 0.39 per year. Of the 14 states with data available in 1999, Iowa had the lowest rate at 0.1 per 1,000 deliveries and Maryland had the highest at 8.2. In 2014, when data were available for 26 states and the District of Columbia, the highest rate was Vermont’s 48.6 per 1,000 deliveries and the lowest was 0.7 in Washington, D.C., the investigators reported.

Although “increasing trends might represent actual increases in prevalence or improved screening and diagnosis,” Ms. Haight and her associates added that “these estimates also correlate with state opioid prescribing rates in the general population. West Virginia, for example, had a prescribing rate estimated at 138 opioid prescriptions per 100 persons in 2012.”


“These findings illustrate the devastating impact of the opioid epidemic on families across the U.S., including on the very youngest,” said CDC Director Robert R. Redfield, MD. “Untreated opioid use disorder during pregnancy can lead to heartbreaking results. Each case represents a mother, a child, and a family in need of continued treatment and support.”

Data for the analysis came from the Agency for Healthcare Research and Quality’s National Inpatient Sample and State Inpatient Databases.

SOURCE: Haight SC et al. MMWR. 2018 Aug 10;67[31]:845-9.

Recommended Reading

Fentanyl analogues an increasing factor in opioid deaths
MDedge Pediatrics
MDedge Daily News: How to handle opioid constipation
MDedge Pediatrics
Drug-related deaths continue to rise in United States
MDedge Pediatrics
NIH launches HEAL Initiative to combat opioid crisis
MDedge Pediatrics
Addiction: Veterans with pain, opioid use disorder
MDedge Pediatrics
Fentanyl analogs nearly double their overdose death toll
MDedge Pediatrics
Assessing adverse events tied to outpatient opioid use in children
MDedge Pediatrics
Opioid use disorder is a chronic condition that needs ongoing therapy
MDedge Pediatrics
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Pediatrics